2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review

Food and Chemical Toxicology

Volumn 43, Issue 10, 2005, Pages 1451-1459

  Gould, Sarah ^a   Scott, Robert C ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

2 hydroxylpropyl cyclodextrin; Toxicology

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN;

CARCINOGENICITY; DIARRHEA; DRUG METABOLISM; DRUG TOLERABILITY; EMBRYO DEVELOPMENT; FETUS DEVELOPMENT; GENETIC TOXICOLOGY; HEMATOLOGY; HISTOPATHOLOGY; HUMAN; INTESTINE TUMOR; KIDNEY; KIDNEY DYSFUNCTION; LIVER; LUNG; NONHUMAN; PANCREAS TUMOR; RABBIT; REVIEW; SAFETY; SOLUBILITY; SPECIES; URINARY TRACT;

ANIMALS; BETA-CYCLODEXTRINS; CARCINOGENS; EXCIPIENTS; HUMANS; MUTAGENS; TERATOGENS; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS;

EID: 21844459973     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2005.03.007     Document Type: Review

References (21)

1. Antlsperger, G., Schmid, G., 1996. Toxicological comparison of cyclodextrins. In: Szejtili, J., Szente, L. (Eds.), Proc. of the 8th Int. Symp. on Cyclodextrins. pp. 149-155.
2. M.E. Brewster, K.S. Estes, and N. Bodor An intravenous toxicity study of 2-HP-β-CD, a useful drug solubiliser, in rats and monkeys Int. J. Pharm. 59 1990 231 243
3. M.E. Bellringer, T.G. Smith, R. Read, C. Gopinath, and P. Olivier β-Cyclodextrin: 52 week toxicity studies in the rat and dog Food Chem. Toxicol. 33 1995 367 376
4. Coussement, W., Van Cauteren, H., Vandenberghe, J., Vanparys, P., Teuns, G., Lampo, A., Marsboom, R., 1990. Toxicological profile of HP-β-CD in laboratory animals. In: Duchene, D. (Ed.), Minutes of the 5th International Symposium on Cyclodextrins. Editions de Sante, pp. 522-524.
5. D.W. Frank, J.E. Gray, and R.N. Weaver Cyclodextrin nephrosis in the rat Am. J. Pathol. 83 1976 367 382
6. W.H. Frijlink, A.C. Eissens, R.N. Hefting, K. Poelstra, C.F. Lerk, and D.K.F. Meijer The effect of parenterally administered cyclodextrins on cholesterol levels in the rat Pharm. Res. 8 1991 9 16
7. Fromming, K.H., Szejtli, J., 1996. Pharmacokinetics and toxicology of cyclodextrins. In: Szejtili, J., Szente, L. (Eds.), Proc. of the 8th Int. Symposium on Cyclodextrins. pp. 33-45 (Chapter 3).
8. Gerloczy, A., Antal, S., Szatmari, I., Muller-Horvath, R., Szejtli, J., 1990. Absorption, distribution and excretion of 14-C; labelled HP-β-CD in rats following oral administration. In: Duchene, D. (Ed.), Minutes of the 5th International Symposium on Cyclodextrins. Editions de Sante. Paris. pp. 507-513.
9. T. Irie, and K. Uekama Pharmaceutical applications of Cyclodextrins. III. Toxicological issues and safety evaluation J. Pharm. Sci. 86 1997 147 162
10. Janssen Technical Bulletin, 1992. Encapsin HPB hydroxypropyl-β- cyclodextrin. A real solution for real drug delivery problems. Janssen Biotech N.V. pp. 1-7.
11. J.L. Messens, P. Putterman, and P. Verheyen D. Duchene New Trends in Cyclodextrins and Derivatives 1991 Editions de Sante Paris 391 407
12. Monbaliu, J., Van Beijstervedt, L., Meuldermans, W., Szathmary, S., Heykants, J., 1990. Disposition of HP-β-CD in experimental animals. In: Duchene, D. (Ed.), Minutes of the 5th International Symposium on Cyclodextrins. Editions de Sante. Paris. pp. 514-517.
13. P. Olivier, F. Verwaerde, and A.R. Hedges Subchronic toxicity of orally administered β-cyclodextrin in rats J. Am. Coll. Toxicol. 10 1991 407 419
14. J.H. Perrin, F.P. Field, D.A. Hansen, R.A. Mufson, and G. Torosian β-cyclodextrin as an aid to peritoneal dialysis. Renal toxicity of β-cyclodextrin in the rat Res. Commun. Chem. Pathol. Pharmacol. 19 1978 373 376
15. Seiller, K.-U., Szathmary, S., Huss, H.J., Coster De, R., Junge, W., 1990. Safety profile and intravenous tolerance of HP-β-CD after increasing single dose. In: Duchene, D. (Ed.), Minutes of the 5th International Symposium on Cyclodextrins. Editions de Sante. Paris. pp. 518-511.
16. Szathmary, S.C., Seiller, K.-U., Luchmann, I., Huss, H.-J., 1990. Pharmacokinetic behaviour and absolute bioavailability of HP-β-CD after increasing doses in volunteers. In: Duchene, D. (Ed.), Minutes of the 5th International Symposium on Cyclodextrins. Editions de Sante, Paris. pp. 535-540.
17. J. Szetjli Introduction and general overview of cyclodextrin chemistry Chem. Rev. 98 1998 1743 1753
18. K. Uekama, F. Hirayama, and T. Irie Cyclodextrin drug carrier system Chem. Rev. 98 1998 2045 2076
19. Van Cauteren, H., Lampo, A., Coussement, W., Lammens, L., Vandenberghe, J., 1997. Acute and chronic preclinical safety profile of encapsin (1997). Personal communication. Pharmaceutical Conference American Association of Pharmaceutical Scientists.
20. WHO, 1993. Toxicological evaluation of certain food additives and contaminants. B-Cyclodextrin. The forty-first meeting of the Joint FAO/WHO Expert Committee on Food Additives. World health Organization, Geneva. WHO Food Additives Series 32, pp. 173-193.
21. A. Yoshida, M. Yamamoto, F. Hirayama, and F. Uekama Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives Chem. Pharm. Bull. (Tokyo) 36 1988 4075 4080